Why Geron, Express, and Herbalife Tumbled Today

The S&P 500 managed to end a two-day losing streak Wednesday with very modest gains, but many stocks couldn't recover from severe losses. Find out what made these three stocks drop today.

Mar 12, 2014 at 8:30PM

The stock market demonstrated its continuing confusion Wednesday, initially falling sharply on ongoing concerns about tension in the Crimea and Chinese economic sluggishness. Yet by the end of the day, the S&P 500 had actually managed to post a gain on the day, once again showing the resiliency of the five-year-old bull market. Unfortunately, though, shareholders in several stocks still suffered substantial losses, with Geron (NASDAQ:GERN), Express (NYSE:EXPR), and Herbalife (NYSE:HLF) among the market's losers today.

Geron plunged 62% after the biotech company got bad news about its key imetelstat drug, as the FDA issued a clinical hold on the treatment for multiple myeloma and essential thrombocythemia. The FDA cited risks of liver damage and abnormal liver-function test results in Geron's phase 2 study, and because of the hold, Geron probably won't be able to start a scheduled myelofibrosis study for imetelstat as soon as it had hoped. With Geron still striving to find a viable long-term business model after having given up on the stem-cell research it had done in the past, any threat to imetelstat's success has severe implications for the company's survival -- as shareholders discovered today.

Express fell 12% as the retailer reported poor financial results and gave discouraging guidance for the coming year. Same-store sales for the fashion company rose 1%, but overall revenue fell a larger-than-expected 2.2%, and earnings also fell short of what investors had hoped to see because of extensive markdowns. Express also said it saw declining same-store sales in the beginning of the new fiscal year, with earnings guidance predicting a 10% to 25% drop in earnings per share from last year's levels. Until retailers stop the cutthroat discounting behavior that has plagued the industry throughout the holiday season, Express and its peers will have trouble recovering fully.

Herbalife dropped 7% after the Federal Trade Commission opened an investigation into the multi-level-marketing retailer. The company has been the subject of an intense battle between high-profile institutional investors, including Bill Ackman on one side and Carl Icahn and others on the other. With Ackman having sold the stock short and having attacked Herbalife vigorously, today's news comes as no surprise to him. But while news of an investigation is never positive, it's too early to tell whether the actual results of the civil probe will reveal anything that hurts the company's long-term prospects -- or reward those who've bet against the stock.

Interestingly, other companies with similar business models were mixed today, with USANA Health (NYSE:USNA) falling 4% but Nu Skin Enterprises (NYSE:NUS) soaring 7% despite Herbalife's news, as investors apparently concluded that Herbalife's troubles won't affect Nu Skin.

Get great stocks into your portfolio
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Dan Caplinger has no position in any stocks mentioned. The Motley Fool has the following options: long January 2015 $50 calls on Herbalife Ltd. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information